ATARA BIOTHERAPEUTICS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 151.85 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-12
- ATARA BIOTHERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 373.74M shares, a 8.17% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 158.68M shares, a 80.02% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 330.18M shares, a 60.33% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 406.98M shares, a 59.36% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 86.23M shares, a 86.58% decline from fiscal 2024.
- ATARA BIOTHERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 642.77M shares, a 6.32% decline from fiscal 2023.
- ATARA BIOTHERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 686.15M shares, a 3907.35% increase from fiscal 2022.
- ATARA BIOTHERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 17.12M shares, a 18.24% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 151.85M shares 10-Q · filed 2026-08-12 | |||||||
| 2026-03-31 | 373.74M shares 10-Q · filed 2026-05-12 | |||||||
| 2025-12-31 | 86.23M shares 10-K · filed 2026-03-16 | |||||||
| 2025-09-30 | 158.68M shares 10-Q · filed 2025-11-12 | 179.32M shares 10-Q · filed 2025-11-12 | ||||||
| 2025-06-30 | 330.18M shares 10-Q · filed 2025-08-11 | 378.02M shares 10-Q · filed 2026-08-12 | ||||||
| 2025-03-31 | 406.98M shares 10-Q · filed 2026-05-12 | |||||||
| 2024-12-31 | 642.77M shares 10-K · filed 2026-03-16 | |||||||
| 2024-09-30 | 794.29M shares 10-Q · filed 2025-11-12 | 794.29M shares 10-Q · filed 2025-11-12 | 794.29K shares 10-Q · filed 2024-11-12 | |||||
| 2024-06-30 | 832.23M shares 10-Q · filed 2025-08-11 | 832.23M shares 10-Q · filed 2025-08-11 | 832.23K shares 10-Q · filed 2024-08-12 | |||||
| 2024-03-31 | 1.00B shares 10-Q · filed 2025-05-15 | 25.04M shares 10-Q · filed 2024-05-09 | ||||||
| 2023-12-31 | 686.15M shares 10-K · filed 2025-03-07 | 17.15M shares 10-K · filed 2024-03-28 | ||||||
| 2023-09-30 | 21.22M shares 10-Q · filed 2023-11-01 | 848.71K shares 10-Q · filed 2024-11-12 | 21.22M shares 10-Q · filed 2023-11-01 | |||||
| 2023-06-30 | 23.38M shares 10-Q · filed 2023-08-08 | 935.27K shares 10-Q · filed 2024-08-12 | 23.38M shares 10-Q · filed 2023-08-08 | |||||
| 2023-03-31 | 24.48M shares 10-Q · filed 2024-05-09 | |||||||
| 2022-12-31 | 17.12M shares 10-K · filed 2024-03-28 | |||||||
| 2022-09-30 | 19.14M shares 10-Q · filed 2023-11-01 | 19.14M shares 10-Q · filed 2023-11-01 | ||||||
| 2022-06-30 | 18.85M shares 10-Q · filed 2023-08-08 | 18.85B shares 10-Q · filed 2022-08-08 | 19.03M shares 10-Q · filed 2023-08-08 | 19.03B shares 10-Q · filed 2022-08-08 | ||||
| 2022-03-31 | 19.01M shares 10-Q · filed 2023-05-08 | |||||||
| 2021-12-31 | 14.48M shares 10-K · filed 2023-02-08 | |||||||
| 2021-09-30 | 14.25M shares 10-Q · filed 2022-11-08 | |||||||
| 2021-06-30 | 14.46B shares 10-Q · filed 2022-08-08 | 14.46B shares 10-Q · filed 2022-08-08 | 14.46M shares 10-Q · filed 2021-08-09 | |||||
| 2021-03-31 | 14.10M shares 10-Q · filed 2022-05-05 | |||||||
| 2020-12-31 | 10.73M shares 10-K · filed 2023-02-08 | |||||||
| 2020-09-30 | 11.32M shares 10-Q · filed 2021-11-04 | |||||||
| 2020-06-30 | 11.92M shares 10-Q · filed 2021-08-09 | |||||||
| 2020-03-31 | 11.91M shares 10-Q · filed 2021-05-04 | |||||||
| 2019-12-31 | 8.87M shares 10-K · filed 2022-02-28 | |||||||
| 2019-09-30 | 9.44M shares 10-Q · filed 2020-11-09 | |||||||
| 2019-06-30 | 8.84M shares 10-Q · filed 2020-08-05 | |||||||
| 2019-03-31 | 8.74M shares 10-Q · filed 2020-05-06 | |||||||
| 2018-12-31 | 7.69M shares 10-K · filed 2021-03-01 | |||||||
| 2018-09-30 | 7.79M shares 10-Q · filed 2019-11-07 | |||||||
| 2018-06-30 | 7.53M shares 10-Q · filed 2019-08-08 | |||||||
| 2018-03-31 | 7.43M shares 10-Q · filed 2019-05-09 | |||||||
| 2017-12-31 | 6.93M shares 10-K · filed 2020-02-27 | |||||||
| 2017-09-30 | 6.68M shares 10-Q · filed 2018-11-06 | |||||||
| 2017-06-30 | 6.30M shares 10-Q · filed 2018-08-01 | |||||||
| 2017-03-31 | 5.62M shares 10-Q · filed 2018-05-08 | |||||||
| 2016-12-31 | 5.03M shares 10-K · filed 2019-02-26 | |||||||
| 2016-09-30 | 5.15M shares 10-Q · filed 2017-11-09 | |||||||
| 2016-06-30 | 4.44M shares 10-Q · filed 2017-08-07 | |||||||
| 2016-03-31 | 4.60M shares 10-Q · filed 2017-05-04 | |||||||
| 2015-12-31 | 3.80M shares 10-K · filed 2018-02-27 | |||||||
| 2015-09-30 | 1.33M shares 10-Q · filed 2015-11-06 | 1.26M shares 10-Q · filed 2015-11-06 | ||||||
| 2015-06-30 | 1.45M shares 10-Q · filed 2015-08-07 | 1.34M shares 10-Q · filed 2015-08-07 | ||||||
| 2015-03-31 | 1.46M shares 10-Q · filed 2015-05-11 | |||||||
| 2014-12-31 | 11.54M shares 10-K · filed 2015-02-26 | |||||||
| 2014-09-30 | 12.93M shares 10-Q · filed 2015-11-06 | 12.95M shares 10-Q · filed 2015-11-06 | ||||||
| 2014-06-30 | 13.00M shares 10-Q · filed 2015-08-07 | 12.96M shares 10-Q · filed 2015-08-07 | ||||||
| 2014-03-31 | 12.92M shares 10-Q · filed 2015-05-11 | |||||||
| 2013-12-31 | 6.59M shares 10-K · filed 2015-02-26 | |||||||
| 2013-09-30 | 6.59M shares 10-Q · filed 2014-11-12 | 5.98M shares 10-Q · filed 2014-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |